Kalyra Pharmaceuticals, Inc. — Department of Defense SBIR Phase II: Non-DOD
Kalyra Pharmaceuticals, Inc. — SBIR Phase II award from Department of Defense.
- Amount
- $999,830
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- Non-DOD
- Solicitation
- 2017.0
- NAICS
- —
- Place of performance
- CA
- Period
- 2017-09-25 → 2019-02-24
Description
There has been considerable interest in the development of alternative therapies for pain management that are neither opioid nor non-steroidal anti-inflammatory drugs (NSAIDs). Kalyra Pharmaceuticals has demonstrated that acetaminophen, also known as APAP